Kevin Robert Frost
GET UPDATES FROM Kevin Robert Frost
Kevin Robert Frost joined amfAR, The Foundation for AIDS Research, in September 1994 and has served as the chief executive officer since March 2007. Beginning in 1998, Mr. Frost began working extensively in Asia, where he facilitated the development of TREAT Asia. This network of more than 50 hospitals, community clinics, NGOs, and healthcare facilities works together with civil society in 17 countries to build the capacity necessary for scaling up treatment efforts in the region. Mr. Frost also served as a member of the international advisory committee for the XIV International AIDS Conference in Barcelona, Spain, and was a member of the Scientific Committee for the XVI International AIDS Conference in Toronto, Canada, in August 2006.

Mr. Frost has served on the advisory panels for three U.S. Food and Drug Administration hearings on a new drug application for Chiron Corporation’s ganciclovir implant; a new drug application for Gilead’s cidofovir; and a review of the application for fomivirsen sodium. He has been published in the Lancet, Journal of Clinical Epidemiology, Journal of AIDS (JAIDS), Journal of Infectious Diseases, and The AIDS Reader.

Prior to joining amfAR, Mr. Frost served as the inpatient care coordinator of the AIDS program at New York City’s Bellevue Hospital. Previously, he was a research assistant at the New York University Medical Center where he worked primarily on clinical research studies of cytomegalovirus retinitis in people with HIV/AIDS.

Blog Entries by Kevin Robert Frost

Ten Years of The Global Fund: a Crossroads and a Choice

1 Comments | Posted January 30, 2012 | 01/30/12 05:38 PM ET

Ten years ago, 19,000 people in Sub-Saharan Africa were the first to receive free HIV treatment. That was 0.1% of all the people living with HIV in the region that year. Paying for these drugs was a bold move by the Botswana government -- one that said to the world,...

Read Post

Thirty Years On, A Stark Choice on AIDS

Posted June 5, 2011 | 06/05/11 01:03 PM ET

Co-authored by Dr. Mathilde Krim, Ph.D.

The report that ushered in an epidemic 30 years ago this week was startling: Five otherwise healthy gay men in Los Angeles had come down with a rare form of pneumonia, and two of them had already died. Unnerving as this news was, none...

Read Post

President Obama's New $5 Billion Investment Is a Welcome Boost for HIV/AIDS Research

Posted October 1, 2009 | 10/01/09 12:36 PM ET

President Barack Obama's announcement on Wednesday that his administration has allocated $5 billion in medical research grants through the Recovery Act is welcome news not only for scientists, but for the American and global populations that will benefit from the breakthroughs and discoveries this investment will inevitably bring about.

...
Read Post

An Unrivaled Ally in the Fight Against AIDS

Posted August 26, 2009 | 08/26/09 06:14 PM ET

With the passing of Senator Edward M. Kennedy early this morning, the U.S. Senate -- indeed, the world -- has lost a champion on a host of important social issues, including HIV/AIDS. Senator Kennedy's work on behalf of people living with HIV/AIDS is unrivaled in the Senate.

My organization...

Read Post

A Crucial Step for Advancing HIV/AIDS Prevention

Posted July 20, 2009 | 07/20/09 06:37 PM ET

Since 1988, the U.S. government has prevented local and state public health authorities from using federal funds to deliver one of the most effective interventions available to combat the HIV and hepatitis C epidemics -- syringe exchange. One sentence in an appropriations bill strictly banned the use of federal money...

Read Post

The Challenge and Opportunity of a National AIDS Strategy

Posted June 9, 2009 | 06/09/09 10:50 AM ET

The clear-sighted federal response to the H1N1 flu outbreak is testament to the value of careful planning and coordinated government action in the midst of a public health threat. It also shines a harsh light on our failure to develop a similar, comprehensive strategy to address one of our country's...

Read Post